Thomas Jefferson University of Philadelphia has successfully completed the first phase of clinical trials using sensors imbedded in the brain to control a MyoPro powered brace worn by a stroke patient, Myomo Inc reports.

The story is detailed by Thomas Jefferson University on its website and via a news report that aired on CBS Sunday Morning.

“This study serves as a proof of concept, a necessary bridge to future studies that would use fully implanted wireless electrodes to improve movement after stroke.”

— Mijail Serruya, MD, PhD, an assistant professor of neurology at Thomas Jefferson University and the study’s principal investigator

“Over a thousand patients, the majority being stroke survivors, have received a MyoPro to restore function in their paralyzed arms using its non-invasive sensors on the surface of the skin of their arms. What the Jefferson research foretells is a day when MyoPro might be controlled without requiring those sensors, just by the patient ‘thinking’ to move his arm or hand.

“This could make it possible to serve patients with insufficient signals in their affected limbs and to wear MyoPro over regular fashion garments, helping to move users one step closer to full independence.”

— Jon Naft, Vice President and General Manager at Myomo

[Source(s): Myomo Inc, Business Wire]

Related Content:
Myomo Enters Joint Venture to Manufacture and Sell Its Products in China
Myomo Receives Certification as a Medicare Provider
Myomo’s MyoPro Issued New Patents